Back to discover
Disease
Bronchiolitis
Late-stage therapeutic developmentEmerging research
1
Publications
18
Clinical trials
1
Associated genes
2024
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2024-04-01JAMA network open
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 4 clinical trials expected to report results, the earliest in Q4 2027.
Upcoming Milestones
- Q4 2027A Phase 1b/2 Study of Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
- Q4 2027Exploratory Study of Airway Basal Stem Cells on Treatment of Pediatric Bronchiolitis Obliterans
- Q1 2028A Phase 3, Open-label, Randomized, Standard of Care-controlled, Parallel Study Arm Study to Demonstrate Efficacy and Safety of ARINA-1 in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) Progression in Participants With a Bilateral Lung Transplant
- Q4 2029Characterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic Features
Major developments
Upcoming trial readoutHigh impact
Results expected Q1 20282026-08-05
Upcoming trial readoutHigh impact
Results expected Q4 20292026-05-08
Clinical MilestonesViewHide
Results expected
- 2026-08-05A Phase 3, Open-label, Randomized, Standard of Care-controlled, Parallel Study Arm Study to Demonstrate Efficacy and Safety of ARINA-1 in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) Progression in Participants With a Bilateral Lung TransplantResults expected Q1 2028
- 2026-06-16A Phase 1b/2 Study of Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell TransplantationResults expected Q4 2027
- 2026-05-08Characterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic FeaturesResults expected Q4 2029
- 2026-01-14Exploratory Study of Airway Basal Stem Cells on Treatment of Pediatric Bronchiolitis ObliteransResults expected Q4 2027
Other updates
- 2026-02-25A Phase III, Extension Clinical Trial to Demonstrate Efficacy and Safety of Liposomal Cyclosprine A Via the PARI Investigational eFlow® Device and SoC in Treating Bronchiolitis Obliterans in Patients Post Single or Double Lung TransplantTerminated
- 2025-11-11Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With BronchiolitisWithdrawn
Activity timeline6
- 2026-08-05ClinicalA Phase 3, Open-label, Randomized, Standard of Care-controlled, Parallel Study Arm Study to Demonstrate Efficacy and Safety of ARINA-1 in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) Progression in Participants With a Bilateral Lung TransplantResults expected Q1 2028
- 2026-06-16ClinicalA Phase 1b/2 Study of Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell TransplantationResults expected Q4 2027
- 2026-05-08ClinicalCharacterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic FeaturesResults expected Q4 2029
- 2026-02-25ClinicalA Phase III, Extension Clinical Trial to Demonstrate Efficacy and Safety of Liposomal Cyclosprine A Via the PARI Investigational eFlow® Device and SoC in Treating Bronchiolitis Obliterans in Patients Post Single or Double Lung TransplantTerminated
- 2026-01-14ClinicalExploratory Study of Airway Basal Stem Cells on Treatment of Pediatric Bronchiolitis ObliteransResults expected Q4 2027
- 2025-11-11ClinicalEfficacy of Magnesium Sulfate Bolus in Pediatric Patients With BronchiolitisWithdrawn
Clinical trials
The current development programme across all trial phases.
Clinical programme
18
6
16
6
Late-stage studies
Recruiting
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Major themes2
- Bronchiolitis1
- COVID-191
Leading journals1
- JAMA network open1
Leading researchers2
- Simões EAF1
- Suss RJ1
Affiliations (unnormalised)2
- Center for Global Health1
- University of Colorado School of Medicine and Children's Hospital Colorado1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Inflammation of the BRONCHIOLES.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.